RxDoctor Payments Data
★ My doctorsLook up a doctor →

Douglas Gibson, MD

Cardiovascular Disease · la Jolla, CANPI 1700838448

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (54.3%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 33 manufacturers reported payments, led by Boston Scientific at 35.0% of the total. Among cardiovascular disease clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$726,943in general payments, 2019–2025

Across 841 payments — averaging $864.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$254K
  • Abbott$200K
  • Acutus Medical, Inc.$163K
  • Medtronic$68K
  • Biosense Webster, Inc.$33K
  • Medical Device Business Services, Inc.$5K
  • plus $3K from 27 others
$1,442,586in research payments, 2019–2025

Across 273 payments — averaging $5284.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$915K
  • Abbott$432K
  • Medical Device Business Services, Inc.$32K
  • Biosense Webster, Inc.$32K
  • Recor Medical Inc$23K
  • Atricure, Inc.$10K

What the payments were for

  • Consulting fees$394,50354%
  • Speaking & faculty fees$278,97438%
  • Grants$1,0450%
  • Travel & lodging$37,6575%
  • Food & beverage$14,7642%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific334$254,492
Abbott200$200,137
Acutus Medical, Inc.47$163,096
Medtronic(2 entities)63$68,270
Biosense Webster, Inc.89$33,390
Medical Device Business Services, Inc.4$5,000
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)15$295
Volta Medical Inc1$276
Pfizer13$259
Novartis8$214
E.r. Squibb & Sons, L.L.C.10$173
Johnson & Johnson9$157
Cardiva Medical, Inc.3$125
Amgen7$125
Stryker2$101
Philips North America LLC4$100
Atricure, Inc.3$88
Irhythm Technologies, Inc.4$78
United Therapeutics Corporation3$76
Kiniksa Pharmaceuticals, Ltd.3$70
Circa Scientific, Inc.1$63
Kestra Medical Technology Services, Inc.1$53
Baxter Healthcare3$46
Esperion Therapeutics, Inc.2$45
AstraZeneca2$44
Kiniksa Pharmaceuticals International, PLC2$39
Novo Nordisk1$24
Cvrx, Inc.2$21
AbbVie1$21
Chiesi USA, Inc.1$20
Viiv Healthcare Company1$18
Bayer1$16
Altathera Pharmaceuticals LLC1$10

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$726,943 in reported general payments places this provider in the 95th percentile of 2,184 cardiovascular disease providers in California.

See all cardiovascular disease providers in California →

Medicare billing

Part B allowed, 2024
$627,612
Medicare patients
1,414
Services billed
2,861

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in la Jolla

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →